Literature DB >> 25380511

A multidisciplinary consensus document on follow-up strategies for patients treated with percutaneous coronary intervention.

Roberta Rossini1, Luigi Oltrona Visconti, Giuseppe Musumeci, Alessandro Filippi, Roberto Pedretti, Corrado Lettieri, Francesca Buffoli, Marco Campana, Davide Capodanno, Battistina Castiglioni, Maria Grazia Cattaneo, Paola Colombo, Leonardo De Luca, Stefano De Servi, Marco Ferlini, Ugo Limbruno, Daniele Nassiacos, Emanuela Piccaluga, Arturo Raisaro, PierFranco Ravizza, Michele Senni, Erminio Tabaglio, Giuseppe Tarantini, Daniela Trabattoni, Alessandro Zadra, Carmine Riccio, Francesco Bedogni, Oreste Febo, Ovidio Brignoli, Roberto Ceravolo, Gennaro Sardella, Sante Bongo, Pompilio Faggiano, Claudio Cricelli, Cesare Greco, Michele Massimo Gulizia, Sergio Berti, Francesco Bovenzi.   

Abstract

The number of percutaneous coronary interventions (PCI) is increasing worldwide. Follow-up strategies after PCI are extremely heterogeneous and can greatly affect the cost of medical care. Of note, clinical evaluations and non-invasive exams are often performed to low risk patients. In the present consensus document, practical advises are provided with respect to a tailored follow-up strategy on the basis of patients' risk profile. Three strategies follow-up have been defined and types and timing of clinical and instrumental evaluations are reported. Clinical and interventional cardiologists, cardiac rehabilitators, and general practitioners, who are in charge to manage post-PCI patients, equally contributed to the creation of the present document.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  health care policy; percutaneous coronary intervention; risk stratification

Mesh:

Year:  2014        PMID: 25380511     DOI: 10.1002/ccd.25724

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  2 in total

1.  Lights and shadows of long-term dual antiplatelet therapy in "real life" clinical scenarios.

Authors:  Marino Scherillo; Plinio Cirillo; Dario Formigli; Giulio Bonzani; Paolo Calabrò; Paolo Capogrosso; Pio Caso; Giovanni Esposito; Rosario Farina; Paolo Golino; Tonino Lanzillo; Franco Mascia; Ciro Mauro; Federico Piscione; Girolamo Sibilio; Bernardino Tuccillo; Bruno Villari; Bruno Trimarco
Journal:  J Thromb Thrombolysis       Date:  2018-11       Impact factor: 2.300

2.  A Therapeutic Pathway in Patients with Chronic Coronary Syndromes: Proposal for Optimization.

Authors:  Raffaele De Caterina; Paolo Calabrò; Gianluca Campo; Roberta Rossini; Simona Giubilato
Journal:  J Clin Med       Date:  2022-04-08       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.